Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
<< vorige    volgende >>
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
           Alle artikelen van de bijbehorende aflevering
                                       Details van artikel 6 van 8 gevonden artikelen
 
 
  Quality of drug label information on QT interval prolongation
 
 
Titel: Quality of drug label information on QT interval prolongation
Auteur: Warnier, Miriam J.
Holtkamp, Frank A.
Rutten, Frans H.
Hoes, Arno W.
de Boer, Anthonius
Mol, Peter G.M.
De Bruin, Marie L.
Verschenen in: International journal of risk & safety in medicine
Paginering: Jaargang 26 (2014) nr. 2 pagina's 89-98
Jaar: 2014-06-05
Inhoud: BACKGROUND: Information regarding QT-prolongation in the drug label may vary between products. This could lead to suboptimal risk minimization strategies. OBJECTIVE: To systematically assess the variation in the extent and content of information on QT prolongation in the summary of product characteristics (SPC) of recently approved medicinal products. METHODS: Drug labels of products centrally approved in Europe between 2006 and 2012 were screened. Of drugs including the term ‘QT’ in the SPC, the message on QT-prolongation (‘no prolongation’/‘unclear drug-QT association’/‘possibly QT-prolongation’/‘QT-prolongation’) and the advice on cautionary measures pertaining to QT-prolongation in the label were examined, as well as their association. RESULTS: Of the 175 screened products, 44 contained information on QT in the SPC (‘no QT-prolongation’: 23%, ‘unclear drug-QT association’: 43%, ‘possibly QT-prolongation’: 16%, ‘QT-prolongation’: 18%). 62% contained advices to act with caution in patients with additional risk factors for QT-prolongation. Products that more likely to have QT-prolonging properties according to the SPC provided more information on QT-prolongation in the SPC (‘no prolongation’: 10% and for the category ‘QT-prolongation’: 100%). CONCLUSIONS: The extent and content of information on QT-prolongation varies considerably between SPCs, and in almost half of the drugs a clear message on QT-prolongation was lacking in the SPC.
Uitgever: IOS Press
Bronbestand: Elektronische Wetenschappelijke Tijdschriften
 
 

                             Details van artikel 6 van 8 gevonden artikelen
 
<< vorige    volgende >>
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland